Postpolio syndrome

G6_POSTPOLIO

postpoliomyelitis syndrome: Postpoliomyelitis syndrome (PPS) is a neurologic disorder characterized by the development of new neuromuscular symptoms such as progressive muscular weakness or abnormal muscle fatigability occurring in survivors of the acute paralytic form of poliomyelitis (see this term), 15-40 years after recovery from the disease, and that is unexplained by other medical causes. Other manifestations that can occur gradually include generalized fatigue, muscle atrophy, muscle and joint pain, intolerance to cold, and difficulties sleeping, swallowing or breathing.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 G14
Hospital discharge: ICD-9 138
Hospital discharge: ICD-8 4499
Cause of death: ICD-10 G14
Cause of death: ICD-9 138
Cause of death: ICD-8 4499

-

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

58

diagram downward connector
G6_POSTPOLIO

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 58 34 24
Unadjusted prevalence (%) 0.02 0.02 0.02
Mean age at first event (years) 49.29 47.28 52.13

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: G6_POSTPOLIO – Postpolio syndrome
GWS hits:

Survival analyses between endpoints

Plot

before Postpolio syndrome
after Postpolio syndrome

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Postpolio syndrome